Brain Stem Gliomas Completed Phase 2 Trials for Capecitabine (DB01101)

Also known as: Brain Stem Glioma / Brainstem Glioma / Glioma of brainstem

IndicationStatusPhase
DBCOND0087392 (Brain Stem Gliomas)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01118377A Study of Capecitabine (Xeloda®) and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem GliomasTreatment